Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study

Netakimab is a humanised camelid-derived monoclonal antibody targeting interleukin-17A. Here, we report the results of post-hoc analysis of the ASTERA phase 3 study (NCT03447704, February 27, 2018) in patients with active radiographic axial spondyloarthritis (r-axSpA) grouped by baseline C-reactive...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical and experimental rheumatology Ročník 41; číslo 3; s. 718
Hlavní autori:	Mazurov, Vadim I, Dubinina, Tatiana V, Erdes, Shandor, Lapshina, Svetlana A, Soroka, Nikolay F, Kunder, Elena V, Smirnov, Alexandr V, Eremeeva, Anna V, Zinkina-Orikhan, Arina V, Morozova, Maria A, Gaydukova, Inna Z
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Italy 01.03.2023
Predmet:	Axial Spondyloarthritis C-Reactive Protein Humans Inflammation - pathology Magnetic Resonance Imaging - methods Sacroiliac Joint - diagnostic imaging Sacroiliac Joint - pathology Sacroiliitis - diagnostic imaging Sacroiliitis - drug therapy Sacroiliitis - pathology Spondylarthritis - diagnostic imaging Spondylarthritis - drug therapy Spondylarthritis - pathology
ISSN:	0392-856X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!